Vir Biotechnology (VIR) Property, Plant & Equipment (Net) (2018 - 2026)

Vir Biotechnology (VIR) Property, Plant & Equipment (Net) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 66,981.90 Bn 66,981.62 Bn - 642,333.36
2 Nanobiotix 1,924.26 Bn 1,924.20 Bn - 5.32 Mn
3 Akari Therapeutics 975.59 Bn 975.59 Bn - -
4 BeOne Medicines 472.11 Bn 467.32 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.89 Bn 114.65 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 69.93 Bn 61.18 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.83 Bn 62.83 Bn - -
8 Argenx Se 55.82 Bn 50.63 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.49 Bn 37.49 Bn - 31.48 Mn
10 Vir Biotechnology 1.32 Bn 1.32 Bn - 53.16 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 53.16 Mn
Mar 31, 2026 53.16 Mn
Dec 31, 2025 55.62 Mn
Dec 31, 2025 55.62 Mn
Sep 30, 2025 58.20 Mn
Sep 30, 2025 58.20 Mn
Jun 30, 2025 60.80 Mn
Jun 30, 2025 60.80 Mn
Mar 31, 2025 61.68 Mn
Mar 31, 2025 61.68 Mn
Dec 31, 2024 63.18 Mn
Dec 31, 2024 63.18 Mn
Sep 30, 2024 64.79 Mn
Sep 30, 2024 64.79 Mn
Jun 30, 2024 66.06 Mn
Jun 30, 2024 66.06 Mn
Mar 31, 2024 92.48 Mn
Mar 31, 2024 92.48 Mn
Dec 31, 2023 96.02 Mn
Dec 31, 2023 96.02 Mn